Loading organizations...
H&D Asset Management is a private equity and venture capital firm based in Taiwan, specializing in investments across pre-IPO and early-stage companies, primarily within the digital technology and biotechnology sectors. The firm provides capital investment and strategic support, following an analysis of portfolio companies' talent, technical capabilities, and market potential. Beyond direct investments, H&D Asset Management also operates as a Limited Partner in various venture capital funds, diversifying its engagement in the startup ecosystem. Its financial activities further extend to comprehensive securities trading, encompassing futures, options, bonds, and equity-oriented securities across multiple markets. The firm's geographic investment footprint is broad, covering Taiwan, Mainland China, the United States, Singapore, Hong Kong, Europe, and India. H&D Asset Management was founded in 2016.
H&D Asset Management has 3 tracked investments across 3 companies. The latest tracked deal is $100.0M Series B in BlossomHill Therapeutics in January 2024.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jan 1, 2024 | BlossomHill Therapeutics | $100.0M Series B | Sundeep Agrawal | General Catalyst, OrbiMed, Sofinnova Investments, Bihua Chen, Hercules Bioventures Partners, Plaisance Capital Management, Timothy Stubbs |
| Jan 19, 2023 | Photoneo | $19.0M Series B Extension | — | AI Capital Partners, Alpha Intelligence Capital, Credo Ventures, Earlybird, IPM Group, Kolowrat Group, Venture TO Future Fund |
| Aug 1, 2021 | Cybavo | $4.0M Seed | 500 Startups, Geeks ON A Plane, H&D Asset Management, NEW Economy Ventures | — |
